@elfolio.bsky.socialLa EMA da su respaldo a Rasonque tras unos resultados que abren una nueva opción frente al cáncer de páncreas metastático. #CancerDePancreas #Rasonque #Daraxonrasib #EMA #Salud #Oncologia #Cancer #Medicina #Investigacion #UnionEuropea #Quimioterapia #felizviernes #16deoctubre
@pharmaphorum.bsky.social#RevolutionMedicines is likely just weeks away from getting #EU approval for its oral #RASinhibitor #Rasonque as a treatment for #pancreaticcancer, after the drug was recommended by the #EMA's human medicines committee.
@desnips.nlEMA keurt alvleesklierkankerpil Rasonque goed die overleving bijna verdubbelt
@natbiotech.nature.comIn Brief: @fda.gov approves $RVMD’s #Rasonque, a first-in-class RAS inhibitor targeting the most common form of pancreatic cancer. An early-stage trial shows that the drug also has promise in lung cancer www.nature.com/articles/s41...
rdcu.be/hJwr1gqQSW3a
@thedailyfathom.bsky.socialBIOTECH · A new cancer pill won FDA approval. Patients can't get it
Rasonque treats a genetic driver of pancreatic cancer, but insurance delays are leaving newly-approved patients stuck for weeks, STAT found.